Kyntra Bio Inc.
KYNB | NASDAQ
$4.57
-$0.08 (-1.72%)
At close: Oct 30, 2026, 4:00 PM ET
$4.69
+$0.12 (+2.63%)
After-hours:
Oct 30, 2026, 5:07 PM ET
Market Data
Market Cap $18.5M
Enterprise Value $-72.81M
Beta 1.05
Average Volume 19.42K
Shares Outstanding (Diluted) 4.05M
Shares Change YoY 0.15%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US31572Q8814
Price Performance
Price Change 1M -31.3%
Price Change 3M -32.1%
Price Change 6M -35.5%
Price Change YTD -48.0%
Price Change 1Y -58.9%
Price Change 3Y -66.2%
Price Change 5Y -98.4%
1M CAGR (ann.) -35.5%
1Y CAGR (ann.) -58.1%
5Y CAGR (ann.) -55.8%
All-Time CAGR -36.3%
Valuation
PE Ratio 0.08
Forward PE N/A
PEG Ratio 0.00
Forward PEG 0.00
PS Ratio 4.01
Forward PS 2.50
PB Ratio -0.61
P/FCF Ratio -0.49
P/Adj. FCF Ratio -0.44
P/OCF Ratio -0.49
EV/Sales -15.77
EV/EBIT 0.77
EV/EBITDA 0.77
EV/FCF 1.91
Earnings Yield 1273.3%
FCF Yield -205.7%
Adj. FCF Yield -227.2%
Financial Health
Net Cash $91.32M
Total Debt $0
Cash & Short-Term Investments $91.32M
Total Assets $101.08M
Current Ratio 2.69
Quick Ratio 2.59
Debt / Equity Ratio 0.00
Debt / EBITDA -0.00
Debt / FCF -0.00
OCF / Debt N/A
Interest Coverage -5.47
Altman Z-Score -25.88
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 18.1%
Operating Profit Margin -1101.0%
EBITDA Margin -2036.0%
Net Profit Margin 3967.8%
FCF Margin -824.4%
Adj. FCF Margin -910.7%
SBC / Revenue 86.3%
SBC Impact (per share) -10.5%
Returns
Return on Assets 181.2%
Return on Equity -605.5%
Return on Invested Capital -78.2%
Return on Capital Employed -78.2%
Return on Tangible Assets 181.2%
Historical Growth (CAGR)
Revenue CAGR 3Y -67.2%
Revenue CAGR 5Y -51.5%
Revenue CAGR 10Y -29.9%
EPS CAGR 3Y 186.5%
EPS CAGR 5Y 135.4%
EPS CAGR 10Y 85.3%
FCF CAGR 3Y 93.5%
FCF CAGR 5Y 32.4%
FCF CAGR 10Y -7.2%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 1
EPS Growth Next 3Y -40.0%
Revenue Growth Next 3Y 20.0%
Earnings Date Nov 9, 2026
EPS Estimate (next Q) -$3.55
EPS Growth Est (next Q) 120.4%
Revenue Est (next Q) $1.77M
Revenue Growth Est (next Q) 64.1%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value $1,454.75
Lynch Upside 31732.6%
Price Target $28.00
Price Target Upside 512.7%
Cash Flow
Operating Cash Flow $-38.05M
Free Cash Flow $-38.06M
Adj. Free Cash Flow $-42.05M
FCF Per Share -$9.40
OCF Per Share -$9.40
OCF/S Ratio -824.2%
Income Statement
Revenue $4.62M
Gross Profit $838K
Operating Income $-50.83M
EBITDA $-94.01M
Net Income $183.19M
EPS (Diluted) $58.19
Revenue / Employee $135.79K
Profit / Employee $5.39M
Employees 34
Add to Watchlist
Select watchlists to add or remove KYNB